Mineralys Therapeutics, Inc. (MLYS) PT Raised to $43 at BofA Securities
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Price: $25.64 -1.72%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA Securities analyst Tim Anderson raised the price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) to $43.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Mineralys Therapeutics, Inc. (MLYS) Misses Q2 EPS by 22c
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
